Key points are not available for this paper at this time.
The advent of mRNA vaccines for COVID-19 has substantially impacted cancer research and treatment methodologies. This study investigates the rapid advancements in mRNA technology spurred by the pandemic and their subsequent acceleration of cancer vaccine research. We examine how these innovations have deepened our understanding of immune responses, improved delivery mechanisms, and opened new possibilities for personalized and combination therapies. The analysis includes a review of ongoing clinical trials and future prospects, supported by recent studies and expert analyses. By analyzing trends in cancer incidence and survival rates before and after the implementation of mRNA technology, this paper provides critical insights into its effects on cancer outcomes.
Syesha Vaish - (2024) studied this question.